Bevyxxa
Total Payments
$437,227
Transactions
2
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $437,227 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,622 | 1 | 59.2% |
| Unspecified | $178,605 | 1 | 40.8% |
Payments by Type
General
$258,622
1 transactions
Research
$178,605
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| APEX Publications | Portola Pharmaceuticals, Inc. | $178,605 | 1 |
Top Doctors Receiving Payments for Bevyxxa
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Interventional Cardiology | Boston, MA | $437,227 | 2 |
Ad
Manufacturing Companies
- Portola Pharmaceuticals, Inc. $437,227
Product Information
- Type Drug
- Total Payments $437,227
- Total Doctors 1
- Transactions 2
About Bevyxxa
Bevyxxa is a drug associated with $437,227 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Portola Pharmaceuticals, Inc..
Payment data is available from 2018 to 2018. In 2018, $437,227 was paid across 2 transactions to 1 doctors.
The most common payment nature for Bevyxxa is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,622, 59.2% of total).
Bevyxxa is associated with 1 research study, including "APEX Publications" ($178,605).